As of 2024-12-15, the EV/EBITDA ratio of Life Science REIT PLC (LABS.L) is 31.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LABS.L's latest enterprise value is 245.61 mil GBP. LABS.L's TTM EBITDA according to its financial statements is 7.91 mil GBP. Dividing these 2 quantities gives us the above LABS.L EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 19.2x | 19.1x |
| Forward P/E multiples | 15.7x - 18.2x | 17.5x |
| Fair Price | 6.09 - 34.83 | 21.85 |
| Upside | -84.2% - -9.5% | -43.3% |
| Date | EV/EBITDA |
| 2024-12-13 | 31.04 |
| 2024-12-12 | 30.91 |
| 2024-12-11 | 30.82 |
| 2024-12-10 | 30.91 |
| 2024-12-09 | 31.04 |
| 2024-12-06 | 30.95 |
| 2024-12-05 | 30.86 |
| 2024-12-04 | 30.77 |
| 2024-12-03 | 30.38 |
| 2024-12-02 | 30.38 |
| 2024-11-29 | 30.25 |
| 2024-11-28 | 30.73 |
| 2024-11-27 | 30.99 |
| 2024-11-26 | 30.64 |
| 2024-11-25 | 30.60 |
| 2024-11-22 | 30.38 |
| 2024-11-21 | 30.95 |
| 2024-11-20 | 31.57 |
| 2024-11-19 | 31.57 |
| 2024-11-18 | 31.26 |
| 2024-11-15 | 32.14 |
| 2024-11-14 | 32.53 |
| 2024-11-13 | 32.58 |
| 2024-11-12 | 32.67 |
| 2024-11-11 | 32.84 |
| 2024-11-08 | 33.02 |
| 2024-11-07 | 32.80 |
| 2024-11-06 | 32.67 |
| 2024-11-05 | 32.58 |
| 2024-11-04 | 32.67 |
| 2024-11-01 | 32.67 |
| 2024-10-31 | 32.49 |
| 2024-10-30 | 32.67 |
| 2024-10-29 | 32.75 |
| 2024-10-28 | 32.58 |
| 2024-10-25 | 31.92 |
| 2024-10-24 | 31.83 |
| 2024-10-23 | 31.70 |
| 2024-10-22 | 31.26 |
| 2024-10-21 | 31.26 |
| 2024-10-18 | 31.26 |
| 2024-10-17 | 32.01 |
| 2024-10-16 | 31.92 |
| 2024-10-15 | 31.74 |
| 2024-10-14 | 31.96 |
| 2024-10-11 | 31.48 |
| 2024-10-10 | 31.52 |
| 2024-10-09 | 31.43 |
| 2024-10-08 | 31.43 |
| 2024-10-07 | 31.48 |